BMO Capital Markets upgraded shares of Omega Healthcare Investors (NYSE:OHI – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Monday, MarketBeat.com reports. The firm currently has $45.00 target price on the real estate investment trust’s stock.
A number of other brokerages also recently weighed in on OHI. Truist Financial upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Scotiabank raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Royal Bank of Canada lifted their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Finally, BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a report on Thursday, October 31st. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $40.18.
View Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Price Performance
Omega Healthcare Investors Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.83%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.
Insider Activity
In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. This trade represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the company. UMB Bank n.a. increased its holdings in Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 516 shares during the last quarter. True Wealth Design LLC bought a new stake in Omega Healthcare Investors in the third quarter worth approximately $31,000. Dunhill Financial LLC acquired a new position in shares of Omega Healthcare Investors during the 3rd quarter worth $31,000. DiNuzzo Private Wealth Inc. acquired a new position in shares of Omega Healthcare Investors during the 3rd quarter worth $33,000. Finally, V Square Quantitative Management LLC raised its holdings in shares of Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after purchasing an additional 323 shares in the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.
About Omega Healthcare Investors
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Recommended Stories
- Five stocks we like better than Omega Healthcare Investors
- What Investors Need to Know to Beat the Market
- How to Master Trading Discipline: Overcome Emotional Challenges
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- How to Invest in Small Cap Stocks
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.